Which glioblastoma patients will respond to immunotherapy?
Scientists have discovered a new biomarker to identify which patients with brain tumors called glioblastomas -- the most common and malignant of primary brain tumors -- might benefit from immunotherapy. The treatment could extend survival for an esti.....»»
Norway to block entry for most Russian tourists, Moscow says it will respond
Norway to block entry for most Russian tourists, Moscow says it will respond.....»»
People Who Work In The Medical Field Are Sharing The Last Words Of Dying Patients, And They Range From Scary To Comforting
People Who Work In The Medical Field Are Sharing The Last Words Of Dying Patients, And They Range From Scary To Comforting.....»»
ShotSpotter improves detection and response to gunfire, but doesn"t reduce crime, research finds
ShotSpotter gunfire detection technology has delivered as promised in terms of enabling police to quickly detect and respond to gunshots in two American cities, research from Northeastern University finds......»»
The next food marketing blitz is aimed at people on new weight-loss drugs
Taking a weight-loss drug? Food makers have just the new food for you. Enlarge (credit: Getty | Jeffrey Greenberg) As new diabetes and weight-loss drugs help patients curb appetites and shed pounds, food manufacturers ar.....»»
Non-invasive zaps to the spinal cord can treat paralysis—but no one knows why
The benefits may seem small, but they can make a world of difference, patients say. Enlarge / Trial participant Sherown Campbell manipulating a Rubik's Cube. (credit: UP-LIFT Trial) With a zap of electricity from well-p.....»»
Researchers reveal new cellular mechanical transducer
A research team has uncovered a novel regulator governing how cells respond to mechanical cues. Their findings appear in Nature Cell Biology......»»
Accenture partners with Mandiant to improve cybersecurity operations
Accenture and Mandiant, part of Google Cloud, are teaming up to collaboratively deliver cyber resilience services to help organizations more efficiently detect, investigate, respond to and recover from cyberattacks. As part of the partnership, Accent.....»»
Nanoparticle researchers develop microfluidic platform for better delivery of gene therapy for lung disease
Drug delivery researchers at Oregon State University have developed a device with the potential to improve gene therapy for patients with inherited lung diseases such as cystic fibrosis......»»
Nord Security unveils NordStellar, a platform for advanced cyber threat detection and response
Nord Security introduces NordStellar, a next-generation threat exposure management platform. Created by developers of VPN solution NordVPN, the enterprise cyber threat exposure management platform helps businesses detect and respond to cyber threats,.....»»
Fruit fly helps unlock clues about how organs, tissue and cancer grow
The fruit fly, Drosophila, has been used by scientists for more than 100 years to unravel key features of life on Earth, such as how animals respond to the sun and how the bodies of animals are patterned from head to tail......»»
African farmers look to the past and the future to address climate change
From ancient fertilizer methods in Zimbabwe to new greenhouse technology in Somalia, farmers across the heavily agriculture-reliant African continent are looking to the past and future to respond to climate change......»»
Three women contract HIV from dirty “vampire facials” at unlicensed spa
Five patients with links to the spa had viral genetic sequences that closely matched. Enlarge / Drops of the blood going onto an HIV quick test. (credit: Getty | BRITTA PEDERSEN) Trendy, unproven "vampire facials" perfor.....»»
Researchers set new standards for nanoparticles, helping patients with MS, ALS, Parkinson"s disease
Is it possible for nanoparticles to go through the digestive system and deliver medicine directly to the brain tissue? Researchers from Michigan State University say yes, and their latest findings are expected to benefit patients with neurodegenerati.....»»
Nanoparticle delivery of FZD4 to lung endothelial cells inhibits lung cancer progression and metastases
A recent study from the lab of Tanya Kalin, MD, Ph.D., professor of Child Health and Internal Medicine at the University of Arizona College of Medicine—Phoenix, has shown potential to improve therapeutic outcomes for patients suffering from lung ca.....»»
Texas surgeon accused of secretly blocking patients from getting transplants
The motive for the alleged data manipulation is unknown. Enlarge (credit: LinkedIn) An accomplished and prominent transplant surgeon in Texas allegedly falsified patient data in a government transplant waiting list, whic.....»»
Global collaboration discovers drug target to combat chronic lung infection
Scientists have discovered a target for the development of a drug to combat a bacterium that can cause chronic lung infection in hospitalized patients, immunocompromised individuals and people with cystic fibrosis......»»
Can the bias in algorithms help us see our own?
Algorithms were supposed to make our lives easier and fairer: help us find the best job applicants, help judges impartially assess the risks of bail and bond decisions, and ensure that health care is delivered to the patients with the greatest need......»»
Akamai Shield NS53 protects on-prem and hybrid DNS infrastructure
Akamai launched Akamai Shield NS53, a product that protects on-premises (on-prem) Domain Name System (DNS) infrastructure from resource exhaustion attacks. These attacks overwhelm servers to the point that they can no longer respond to valid DNS quer.....»»
Clocks going forward can catch investors napping: How investors" reactions are affected by sleep disruption
Clocks losing an hour in spring significantly affects how investors respond to companies that reveal unexpected levels of earnings, research shows......»»
$158,000 ALS drug pulled from market after failing in large clinical trial
The drug is now unavailable to new patients; its maker to lay off 70% of employees. Enlarge (credit: Amlyx) Amylyx, the maker of a new drug to treat ALS, is pulling that drug from the market and laying off 70 percent of.....»»